Chiron Capital Management, LLC Tyme Technologies, Inc. Transaction History

Chiron Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Mar 05, 2021	SELL	$0.87 - $1.26 $3,915 - $5,670	-4,500 Closed	0 $0
Q3 2020 Nov 19, 2020	BUY	$0.93 - $1.35 $4,185 - $6,075	4,500 New	4,500 $4,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Capital Management, LLC with notifications on news.